Google would prohibit websites and apps from running ads on content about the coronavirus pandemic against scientific consensuses, such as conspiracy theories.
The conspiracy theories include the notion that the Chinese devised the novel coronavirus as a biological weapon, that Microsoft Corp founder Bill Gates conceived it, or it is a hoax.
The largest search engine updated its policy to do more to clamp down on misinformation, which includes.
Google’s new policy bars advertisers from using its technology or creating ads to disseminate conspiracy theories.
Google already disallows ads like “miracle” health remedies, campaigns against vaccination, and those that encourage those topics.
Only certain institutions are allowed to run ads at Google about the COVID-19 pandemic, including healthcare providers and government organizations, to curtail price-gouging on medical supplies and other undesirable activities.


Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Thailand Inflation Remains Negative for 10th Straight Month in January
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 



